Baxion
Screening
Tags
Alerts
Theme
Fulcrum Therapeutics, Inc.
FULC
·
NASDAQ
·
$6.76
Share Price as of 11/2
·
$366M
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
10-Q
Q2 ended 06/30/26
07/30/26
10-Q
Q1 ended 03/31/26
04/27/26
10-K
FY 2025
02/24/26
10-Q
Q3 ended 09/30/25
10/29/25
10-Q
Q2 ended 06/30/25
07/29/25
Disclosures
Filter
8-K
Current report
08/17/26
8-K
Current report
08/10/26
8-K
Current report
06/25/26
8-K
Current report
06/11/26
8-K
Current report
06/04/26
Prospectuses and Registrations
Filter
S-4/A
Registration (business combination, amended)
10/20/26
S-4/A
Registration (business combination, amended)
10/08/26
S-4
Registration (business combination)
09/02/26
S-8
Registration of securities for employees
02/24/26
424B5
Prospectus supplement
12/11/25
Proxies
Filter
DEF 14A
Definitive proxy
04/30/26
DEFA14A
Additional proxy materials
04/30/26
DEFR14A
Definitive proxy (revised)
05/07/25
DEF 14A
Definitive proxy
04/30/25
DEFA14A
Additional proxy materials
04/30/25
Ownership
Filter
SC 13G/A
Beneficial ownership (amended)
10/27/26
144
Proposed sale of securities
09/02/26
SC 13G
Beneficial ownership
08/14/26
SC 13G/A
Beneficial ownership (amended)
08/14/26
SC 13G/A
Beneficial ownership (amended)
08/14/26
Other
Filter
425
425
08/17/26
425
425
08/17/26
425
425
08/17/26
ARS
Annual report to shareholders
04/30/26
ARS
Annual report to shareholders
04/30/25
Latest Filings
Filter
S-4/A
Registration (business combination, amended)
10/20/26
S-4/A
Registration (business combination, amended)
10/08/26
S-4
Registration (business combination)
09/02/26
8-K
Current report
08/17/26
425
425
08/17/26
Ownership
Filter
SC 13G/A
Beneficial ownership (amended)
10/27/26
144
Proposed sale of securities
09/02/26
SC 13G
Beneficial ownership
08/14/26
SC 13G/A
Beneficial ownership (amended)
08/14/26
SC 13G/A
Beneficial ownership (amended)
08/14/26